Gastrointestinal discomfort is a common condition associated with aging, low levels of physical activity, and reduced intake of fibre, water, and magnesium. Several studies have reported a positive association between the consumption of hyper-mineral water containing high levels of bicarbonate, calcium, or magnesium and improvements in gastrointestinal transit. There is evidence that magnesium and sulphate, individually, exert a laxative effect; however, the impact of other minerals remains limited. Different mechanisms have been described to explain how the gut microbiota influences gastrointestinal transit. It is important to understand the characteristics of the gut microbiota and to determine whether the intake of hyper-mineral water, a natural source of minerals, can positively modulate it. The aim of this randomized, placebo-controlled trial is to evaluate the effects of carbonated mineral water consumption on gastrointestinal transit and gut microbiota composition.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
30
Participants consume 1000 mL per day of natural carbonated mineral water for 4 weeks, divided into four portions: before breakfast, 30 minutes before lunch, during the afternoon, and 30 minutes before dinner. Any additional water intake, if desired, is provided by the study investigators and consists exclusively of low-mineral water in both study arms. Participants record their total weekly water consumption using an electronic form.
Participants consume 1000 mL per day of low-mineral water for 4 weeks, divided into four portions: before breakfast, 30 minutes before lunch, during the afternoon, and 30 minutes before dinner. Any additional water intake, if desired, is provided by the study investigators and consists exclusively of low-mineral water in both study arms. Participants record their total weekly water consumption using an electronic form.
NOVA Medical School | Faculdade de Ciências Médicas da Universidade NOVA
Lisbon, Portugal
Difference between the intervention and control group in the change in gastrointestinal transit from baseline to the end of follow-up (4 weeks).
Change in gastrointestinal transit measured by the percentage of responder subjects defined as a composite score of the two following Rome IV criteria: number of stools ≥ 4 or an increase of 2 stools/week and stools consistency with less than 25% of lumpy to hard stools.
Time frame: 4 weeks
Difference between the intervention and control group in the change in stool consistency from baseline to the end of follow-up (4 weeks).
Change in stool consistency measured using Bristol scale.
Time frame: 4 weeks
Difference between the intervention and control group in the change in constipation symptoms from baseline to the end of follow-up (4 weeks).
Change in constipation symptoms measured using a validated PAC-SYM questionnaire. PAC-SYM is a 12-item, self-administered questionnaire used to measure severity of symptoms over the past 2 weeks in patients with constipation. Cultural adaptation and linguistic validation of the PAC-SYM for Portugal was performed by Mapi Research.
Time frame: 4 weeks
Difference between the intervention and control group in the change in constipation Quality of Life from baseline to the end of follow-up (4 weeks).
Change in constipation Quality of Life measured using a validated PAC-QOL questionnaire. PAC-QOL questionnaire is a 28-item self-administered questionnaire that is being used to measure health-related quality of life (over the past 2 weeks) in patients with chronic constipation. Cultural adaptation and linguistic validation of the PAC-QOL for Portugal was performed by Mapi Research Trust.
Time frame: 4 weeks
Difference between the intervention and control group in the change in Perceived Stress Scale from baseline to the end of follow-up (4 weeks).
Change in constipation Perceived Stress Scale measured using a validated Perceived Stress Scale questionnaire. A validated Perceived Stress Scale (PSS) self-administered questionnaire with 13-item will be used to measure perceived stress of respondents during the last month (Portuguese version keeps 13 of the 14 original items). The PSS questionnaire has been demonstrated to have internal consistency, reproducibility, validity, and sensitivity. Cultural adaptation and linguistic validation of the PSS for Portugal was implemented by Pais-Ribeiro \& Marques (2009).
Time frame: 4 weeks
Difference between the intervention and control group in the change in gut microbiota from baseline to the end of follow-up (4 weeks).
Bacterial DNA will be extracted from fecal samples. 16SRNA gene will be sequenced by next-generation sequencing (NGS). All the identified bacterial phyla, genus and species will be expressed in percentage.
Time frame: 4 weeks
Difference between the intervention and control group in the change in short-chain fatty acid profiling from baseline to the end of follow-up (4 weeks).
Change in short-chain fatty acid profiling evaluated by the faeces concentration of short-chain fatty acids before and after intervention.
Time frame: 4 weeks
Difference between the intervention and control group in the change in urinary excretion of minerals from baseline to the end of follow-up (4 weeks).
Change in urinary excretion of minerals evaluated by the K+, Na+, Mg2+ and Ca2+ excretion before and after intervention.
Time frame: 4 weeks
Difference between the intervention and control group in the change in urinary pH from baseline to the end of follow-up (4 weeks).
Change in urinary pH evaluated by the urine pH before and after intervention.
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.